International Journal of Hematology

Search all International Journal of Hematology articles

Volume 91, Issue 5

June 2010

30 articles in this issue

Extramedullary plasmacytoma of the dura mimicking meningioma
Masahiro Manabe
Hiroshi Kanashima
Hirofumi Teshima
Images in Hematology 15 May 2010 Pages: 731 - 732
¹¹C-Methionine PET/CT for multiple myeloma
Masatoshi Nishizawa
Yuji Nakamoto
Kouhei Yamashita
Images in Hematology 15 May 2010 Pages: 733 - 734
Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?
Tim C. P. Somervaille
Michael L. Cleary
Progress in Hematology 08 May 2010 Pages: 735 - 741
Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting
Rihab Nasr
Hugues de Thé
Progress in Hematology 11 May 2010 Pages: 742 - 747
Molecular pathways to CML stem cells
Kristen N. Rice
Catriona H. M. Jamieson
Progress in Hematology 10 June 2010 Pages: 748 - 752
Evi-1 as a critical regulator of leukemic cells
Susumu Goyama
Mineo Kurokawa
Progress in Hematology 08 June 2010 Pages: 753 - 757
High frequency of MEFV gene mutations in patients with myeloid neoplasm
Cagatay Oktenli
Ozkan Sayan
Selim Nalbant
Rapid Communication 01 May 2010 Pages: 758 - 761
Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity
Wilma Barcellini
Nicoletta Revelli
Alberto Zanella
Original Article 08 May 2010 Pages: 762 - 769
Clinical course of non-severe aplastic anemia in adults
Ji Hyun Kwon
Inho Kim
Byoung-Kook Kim
Original Article 05 June 2010 Pages: 770 - 775
Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
Masahiro Ieko
Mika Yoshida
Takao Koike
Original Article 21 May 2010 Pages: 776 - 783
Mutation analysis of factor VIII in Korean patients with severe hemophilia A
Chur-Woo You
Hee-Sook Son
Haing-Woon Baik
Original Article 10 June 2010 Pages: 784 - 791
Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers
Jacek Treliński
Agnieszka Wierzbowska
Krzysztof Chojnowski
Original Article 15 May 2010 Pages: 792 - 798
Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
Yasunobu Nagata
Kazuteru Ohashi
Hisashi Sakamaki
Original Article 20 April 2010 Pages: 799 - 807
Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma
Keiko Onda
Kazutoshi Iijima
Nobutaka Kiyokawa
Original Article 29 April 2010 Pages: 808 - 819
Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience
Hong Wang
Liangchun Hao
Shuang Bian
Original Article 13 May 2010 Pages: 820 - 825
A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center
Joen Chiang
Alexandre Chan
Soon Thye Lim
Original Article 13 May 2010 Pages: 826 - 830
Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype: a study by the Japanese Childhood AML Cooperative Study Group
Yasuhiro Mizushima
Tomohiko Taki
Souichi Adachi
Original Article 22 May 2010 Pages: 831 - 837
Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Côte d’Ivoire
Gustave Kouassi Koffi
Aissata Tolo
Ibrahima Sanogo
Original Article 18 May 2010 Pages: 838 - 843
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports
Tatsuya Yoshida
Shigeru Kusumoto
Ryuzo Ueda
Original Article 15 May 2010 Pages: 844 - 849
Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group
Samart Pakakasama
Gavivann Veerakul
Somjai Kanjanapongkul
Original Article 20 May 2010 Pages: 850 - 854
Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
Koji Nagafuji
Keitaro Matsuo
Mine Harada
Original Article 14 May 2010 Pages: 855 - 864
Late effects and quality of life of childhood cancer survivors: Part 1. Impact of stem cell transplantation
Yasushi Ishida
Misato Honda
Keizo Horibe
Original Article 15 May 2010 Pages: 865 - 876
Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion
Martin Schmidt-Hieber
S. Schwarck
I. W. Blau
Original Article 21 May 2010 Pages: 877 - 885
A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation
Seung Tae Kim
Mark H. Lee
Chul Won Jung
Original Article 08 May 2010 Pages: 886 - 891
Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer
Sang Ouk Chin
Jae Jin Lee
Cheong Woong Choi
Case Report 29 April 2010 Pages: 892 - 896
Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher plasma levels and major molecular response
Edgar Faber
David Friedecký
Tomáš Adam
Case Report 01 May 2010 Pages: 897 - 902
Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma
Hiroyuki Takamatsu
Takeshi Yamashita
Shinji Nakao
Case Report 11 May 2010 Pages: 903 - 906
Mast cell activation disorder masquerading as pure red cell aplasia
Lawrence B. Afrin
Letter to the Editor 08 June 2010 Pages: 907 - 908
Prevention of venous thromboembolism according to the guidelines of a domestic manual
Toshihiro Kaneko
Hideo Wada
Masaaki Ito
Letter to the Editor 21 May 2010 Pages: 909 - 911
Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia
Jun Kato
Takehiko Mori
Shinichiro Okamoto
Letter to the Editor 14 April 2010 Pages: 912 - 913

Volume 91, Issue 5

Extramedullary plasmacytoma of the dura mimicking meningioma

¹¹C-Methionine PET/CT for multiple myeloma

Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?

Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting

Molecular pathways to CML stem cells

Evi-1 as a critical regulator of leukemic cells

High frequency of MEFV gene mutations in patients with myeloid neoplasm

Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity

Clinical course of non-severe aplastic anemia in adults

Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation

Mutation analysis of factor VIII in Korean patients with severe hemophilia A

Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers

Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion

Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma

Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience

A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center

Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype: a study by the Japanese Childhood AML Cooperative Study Group

Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Côte d’Ivoire

Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports

Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group

Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry

Late effects and quality of life of childhood cancer survivors: Part 1. Impact of stem cell transplantation

Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion

A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation

Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer

Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher plasma levels and major molecular response

Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma

Mast cell activation disorder masquerading as pure red cell aplasia

Prevention of venous thromboembolism according to the guidelines of a domestic manual

Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia

Journal navigation